Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

DSM and Crucell sign licensing agreement with Masterclone to develop antibody

July 11, 2007

DelSite provides update on GelVac

June 29, 2007

Kurve Technology and Schering-Plough sign expanded technology agreement

June 14, 2007

Archemix signs aptamer agreements

June 13, 2007

Eurand and GSK reach milestone in orally disintegrating tablet collaboration

June 8, 2007

Progress on gene therapies reported

June 8, 2007

Takeda licenses BioWa's Potelligent technology for antibody development

May 31, 2007

EpiStem begins biomarker feasibility studies with AstraZeneca

May 30, 2007

AAGP increases recovery rate of cryopreserved stem cells

May 25, 2007

Trubion expands research agreement with Dyax

May 24, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...